CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $70,369,463
- in 12 filings, $45.5M under 10b5-1 plans
Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Torti Frank President and Vant Chair | Other disposition | −329,550 | $40.36 | $13.3M | 12,382,243 |
| 2026-11-12 | Torti Frank President and Vant Chair | Other disposition | −62,493 | $41.13 | $2.6M | 12,319,750 |
| 2026-11-12 | Torti Frank President and Vant Chair | Shares withheld for taxes | −12,800 | $41.85 | $536K | 12,306,950 |
| 2026-11-11 | Torti Frank President and Vant Chair | Other disposition | −240,755 | $41.63 | $10.0M | 12,863,086 |
| 2026-11-11 | Torti Frank President and Vant Chair | Other disposition | −151,293 | $42.01 | $6.4M | 12,711,793 |
| 2026-11-10 | Torti Frank President and Vant Chair | Other disposition | −173,683 | $40.43 | $7.0M | 13,322,210 |
| 2026-11-10 | Torti Frank President and Vant Chair | Other disposition | −218,369 | $41.13 | $9.0M | 13,103,841 |
| 2026-09-30 | Torti Frank President and Vant Chair | Shares withheld for taxes | +40,309 | $36.57 | $1.5M | 13,495,893 |
| 2026-06-30 | Torti Frank President and Vant Chair | Shares withheld for taxes | −40,310 | $35.39 | $1.4M | 13,536,202 |
| 2026-03-31 | Torti Frank President and Vant Chair | Shares withheld for taxes | −160,035 | $27.70 | $4.4M | 13,576,512 |
| 2026-02-23 | Torti Frank President and Vant Chair | Option exercise 10b5-1 | +587,390 | $3.85 | $2.3M | 14,323,937 |
| 2026-02-23 | Torti Frank President and Vant Chair | Sale 10b5-1 | −587,390 | $27.51 | $16.2M | 13,736,547 |
| 2026-02-23 | Torti Frank President and Vant Chair | Option exercise · Stock Option (Right to Buy) 10b5-1 | −587,390 | 3,026,184 | ||
| 2026-02-20 | Torti Frank President and Vant Chair | Option exercise 10b5-1 | +1,012,610 | $3.85 | $3.9M | 14,749,157 |
| 2026-02-20 | Torti Frank President and Vant Chair | Sale 10b5-1 | −1,012,610 | $27.15 | $27.5M | 13,736,547 |
| 2026-02-20 | Torti Frank President and Vant Chair | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,012,610 | 3,613,574 | ||
| 2026-02-19 | Torti Frank President and Vant Chair | Option exercise 10b5-1 | +1,400,000 | $3.85 | $5.4M | 15,136,547 |
| 2026-02-19 | Torti Frank President and Vant Chair | Sale 10b5-1 | −1,400,000 | $27.42 | $38.4M | 13,736,547 |
| 2026-02-19 | Torti Frank President and Vant Chair | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,400,000 | 4,626,184 | ||
| 2025-12-24 | Torti Frank President and Vant Chair | Other disposition | −64,891 | $22.47 | $1.5M | 13,847,036 |
Page 1 of 2 · 24 trades